Want to join the conversation?
$ZTS, which produces medicine and vaccinations for pets and livestock, posted 4Q15 net income of $22MM or $0.04 per diluted share, a decrease of 83% and 84%, respectively, compared to 4Q14. The decrease was mainly driven by charges related to changes in the company's accounting for operations in Venezuela. Revenue was $1.3Bil, down 3% from 4Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.